Surprising safety outcomes of urate-lowering therapy [PDF]
Nature Reviews Rheumatology, 2018 openaire +2 more sources
Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations [PDF]
, 2017 Hiroshi Miyata +5 more
core +1 more source
The British Society For Rheumatology guideline for the management of gout [PDF]
, 2017 Cameron, Stewart +13 more
core +2 more sources
Beliefs of rheumatologists and general practitioners on urate lowering therapy: a cross-sectional study. [PDF]
Rheumatol Adv Pract, 2023 Veenstra F +7 more
europepmc +1 more source
Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England. [PDF]
Rheumatology (Oxford), 2023 Russell MD +8 more
europepmc +1 more source
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions. [PDF]
Br J Clin Pharmacol, 2022 Coleshill MJ +9 more
europepmc +1 more source
Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry. [PDF]
Sci Rep, 2023 Do H +16 more
europepmc +1 more source
Initiation of Urate Lowering Therapy (ULT)
The Singapore Family Physician, 2019 Meng Kam Richard Lee, Yee Nah Anita Lim
openaire +2 more sources
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study. [PDF]
Rheumatology (Oxford), 2023 Hu S +19 more
europepmc +1 more source
When underlying biology threatens the randomization principle - initial gout flares of urate-lowering therapy. [PDF]
Nat Rev Rheumatol, 2022 Choi HK, Zhang Y, Dalbeth N.
europepmc +1 more source